Veracyte (NASDAQ: VCYT) reported Q3 EPS of ($0.32), $0.01 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $12.3 million versus the consensus estimate of $12.72 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.